VLA84

VLA84 vaccine · Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLA84, covering 2017-06-08 to 2017-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study [Phase 2]

See pricing